Article History
Received: 17 April 2024
Accepted: 12 June 2024
First Online: 26 June 2024
Declarations
:
: AO received speaker honoraria from Bristol-Myers Squibb, Ono Pharmaceutical, Daiichi Sankyo, and Taiho Pharmaceutical Co. K. Yamaguchi received speaker honoraria from Chugai Pharmaceutical Co. Ltd., Bristol-Myers Squibb, Merck Serono, Taiho Pharmaceutical Co., Takeda, and Eli Lilly; a consultant fee from Takeda Pharmaceutical Co. Ltd.; honoraria from Tsumura Co. Ltd., Nihon Kayaku Co. Ltd., and Chugai Pharmaceutical Co. Ltd; research grants from Sumitomo Dainippon Pharma, Gilead Sciences, MSD, Boehringer Ingelheim, Daiichi Sankyo, and Chugai Pharmaceutical Co. Ltd; and speaker honoraria, research grants, and scholarship grants from Ono Pharmaceutical, Yakult Honsha Co., Ltd., and Sanofi.
: N/A.
: N/A
: N/A